Similarly, HKL treatment prevented and also reverted the development of hypertrophy and fibrosis, and the induction of hypertrophic markers (Pillai et al., 2015, 2017), thus indicating that SIRT3 not only protects against cardiac hypertrophy but can also revert it. Here, SIRT3 is linked to cardiac hypertrophy.